Iceland vs United Arab Emirates: Deaths from Parkinson's disease
Iceland
38.31 deaths
in 2021
United Arab Emirates
45.41 deaths
in 2021
Iceland rank
146th
United Arab Emirates rank
143rd
Deaths from Parkinson's disease over time
- Iceland
- United Arab Emirates
How they compare
United Arab Emirates currently reports 45.41 deaths against 38.31 deaths in Iceland, a difference of 7.1 deaths.
That makes United Arab Emirates's figure about 1.2 times Iceland's.
The two have swapped places 5 times across 22 shared years of data; in 2000 it was Iceland ahead.
Iceland ranks 146th and United Arab Emirates ranks 143rd of 194 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iceland | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.21 deaths | 21.67 deaths | 1.53 deaths | Iceland |
| 2010s | 36.32 deaths | 28.01 deaths | 8.31 deaths | Iceland |
| 2020s | 39.08 deaths | 38.55 deaths | 0.53 deaths | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from parkinson's disease, Iceland or United Arab Emirates?
- United Arab Emirates, at 45.41 deaths against 38.31 deaths in Iceland as of 2021.
- What is the difference in deaths from parkinson's disease between Iceland and United Arab Emirates?
- 7.1 deaths, with United Arab Emirates ahead.
- How many years of comparable data are there for Iceland and United Arab Emirates?
- 22 years are reported by both, from 2000 to 2021.
- How do Iceland and United Arab Emirates rank globally for deaths from parkinson's disease?
- Iceland ranks 146th and United Arab Emirates ranks 143rd of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes.